Skip to main content Back to Top
Advertisement

7/1/2020

Prednisone Oral Tablets

Products Affected - Description

    • Prednisone oral tablet, Cadista, 10 mg, bottle, 500 count, NDC 59746-0173-09 - discontinued
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 1000 count, NDC 59746-0175-10 - discontinued
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 100 count, NDC 00054-4741-25
    • Prednisone oral tablet, Hikma, 1 mg, bottle, 1000 count, NDC 00054-4741-31
    • Prednisone oral tablet, Hikma, 1 mg, unit-dose blister pack, 100 count, NDC 00054-8739-25
    • Prednisone oral tablet, Hikma, 2.5 mg, unit-dose blister pack, 100 count, NDC 00054-8740-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 100 count, NDC 00054-0018-25
    • Prednisone oral tablet, Hikma, 20 mg, bottle, 500 count, NDC 00054-0018-29
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 1000 count, NDC 00054-4728-31
    • Prednisone oral tablet, Hikma, 50 mg, bottle, 100 count, NDC 00054-0019-25

Reason for the Shortage

    • Cadista has all prednisone tablet presentations available. Cadista discontinued the 10 mg tablets in 500 count bottles and the 20 mg tablets in 1000 count bottles.
    • Hikma is allocating prednisone tablets to ensure all customers get adequate supply during COVID-19.
    • Par has prednisone tablets available.
    • Teva had prednisone tablets on shortage due to manufacturing delays.

Available Products

    • Prednisone oral tablet, Cadista, 1 mg, bottle, 100 count, NDC 59746-0171-06
    • Prednisone oral tablet, Cadista, 1 mg, bottle, 1000 count, NDC 59746-0171-10
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 100 count, NDC 59746-0173-06
    • Prednisone oral tablet, Cadista, 10 mg, bottle, 1000 count, NDC 59746-0173-10
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 100 count, NDC 59746-0175-06
    • Prednisone oral tablet, Cadista, 20 mg, bottle, 500 count, NDC 59746-0175-09
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 100 count, NDC 59746-0172-06
    • Prednisone oral tablet, Cadista, 5 mg, bottle, 1000 count, NDC 59746-0172-10
    • Prednisone oral tablet, Hikma, 10 mg, bottle, 100 count, NDC 00054-0017-25
    • Prednisone oral tablet, Hikma, 10 mg, bottle, 500 count, NDC 00054-0017-29
    • Prednisone oral tablet, Hikma, 10 mg, unit-dose blister pack, 100 count, NDC 00054-0017-20
    • Prednisone oral tablet, Hikma, 2.5 mg, bottle, 100 count, NDC 00054-4742-25
    • Prednisone oral tablet, Hikma, 20 mg, unit-dose blister pack, 100 count, NDC 00054-0018-20
    • Prednisone oral tablet, Hikma, 5 mg, bottle, 100 count, NDC 00054-4728-25
    • Prednisone oral tablet, Hikma, 5 mg, unit-dose blister pack, 100 count, NDC 00054-8724-25
    • Prednisone oral tablet, Hikma, 50 mg, unit-dose blister pack, 100 count, NDC 00054-0019-20
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 100 count, NDC 00603-5335-21
    • Prednisone oral tablet, Par Pharmaceuticals, 1 mg, bottle, 1000 count, NDC 00603-5335-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 100 count, NDC 00603-5338-21
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 500 count, NDC 00603-5338-28
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, bottle, 1000 count, NDC 00603-5338-32
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 21 count, NDC 00603-5338-15
    • Prednisone oral tablet, Par Pharmaceuticals, 10 mg, unit-dose blister pack, 48 count, NDC 00603-5338-31
    • Prednisone oral tablet, Par Pharmaceuticals, 2.5 mg, bottle, 100 count, NDC 00603-5336-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 100 count, NDC 00603-5339-21
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 500 count, NDC 00603-5339-28
    • Prednisone oral tablet, Par Pharmaceuticals, 20 mg, bottle, 1000 count, NDC 00603-5339-32
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 100 count, NDC 00603-5337-21
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, bottle, 1000 count, NDC 00603-5337-32
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 21 count, NDC 00603-5337-15
    • Prednisone oral tablet, Par Pharmaceuticals, 5 mg, unit-dose blister pack, 48 count, NDC 00603-5337-31
    • Prednisone oral tablet, Teva, 10 mg, bottle, 100 count, NDC 00591-5442-01
    • Prednisone oral tablet, Teva, 10 mg, bottle, 500 count, NDC 00591-5442-05
    • Prednisone oral tablet, Teva, 10 mg, bottle, 1000 count, NDC 00591-5442-10
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 21 count, NDC 00591-5442-21
    • Prednisone oral tablet, Teva, 10 mg, unit-dose blister pack, 48 count, NDC 00591-5442-43
    • Prednisone oral tablet, Teva, 20 mg, bottle, 100 count, NDC 00591-5443-01
    • Prednisone oral tablet, Teva, 20 mg, bottle, 500 count, NDC 00591-5443-05
    • Prednisone oral tablet, Teva, 20 mg, bottle, 1000 count, NDC 00591-5443-10
    • Prednisone oral tablet, Teva, 5 mg, bottle, 100 count, NDC 00591-5052-01
    • Prednisone oral tablet, Teva, 5 mg, bottle, 1000 count, NDC 00591-5052-10
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 21 count, NDC 00591-5052-21
    • Prednisone oral tablet, Teva, 5 mg, unit-dose blister pack, 48 count, NDC 00591-5052-43

Estimated Resupply Dates

    • Hikma is allocating prednisone tablets. Customers are receiving orders in full and there are no issues supporting existing customer demands.

Updated

Updated July 1, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 15, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.